Device
Rhythmia Mapping System
Rhythmia Mapping System is a medical device with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Trials by Status
recruiting133%
completed267%
Recent Activity
1 active trials
Showing 3 of 3
recruiting
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
NCT03053141
completed
Prospective Registry on User Experience With The Mapping System For Ablation Procedures
NCT02698670
completed
Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
NCT03094221
Clinical Trials (3)
Showing 3 of 3 trials
NCT03053141
RHythmia mAPping and Signal acquisitiOn for Data analYsis (RHAPSODY)
NCT02698670
Prospective Registry on User Experience With The Mapping System For Ablation Procedures
NCT03094221
Clinical Utility and Validation of the Rhythmia Mapping System for the Treatment of Cardiac Arrhythmias
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3